The DAX Index held steady this week and moved close to the all-time high of €25,433 as the recent bull run gained steam. It has jumped by over 36% from its lowest level in April last year, making it ...
Bayer and Merck & Co, Inc. said heart-failure drug candidate vericiguat didn't meet the primary target of a late-stage study. The German conglomerate on Monday said vericiguat in the phase 3 Victor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results